All of 23andMe's independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company.

Board memebers quit as founder Anne Wojcicki works to come up with an acceptable financial offer to purchase its remaining shares and take the company private.

The biotech company 23andMe has a big mess to clean up after its entire board resigned to protest its CEO’s plans to take the genetic-testing company private.The stock is down more than 63% so far this year,

Seven independent members of the company’s board resigned Tuesday, concluding that despite co-founder and CEO Anne Wojcicki’s expressed intention to take the company private, “no such proposal is forthcoming.

All seven independent directors of DNA-testing company 23andMe resigned, following a protracted negotiation with CEO Anne Wojcicki over her plan to take the company private.

All of 23andMe's independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company. The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki,

Ann Wojcicki, CEO and co-founder of 23andMe, says she is still planning to take the genetic-testing company private despite the resignation this week of the entire board of directors. "After months of work,

Days after proposing to settle a data breach lawsuit for $30 million, 18-year-old genetic testing company 23andMe now faces another public hurdle: Seven independent directors of its board resigned on Tuesday through a pointed letter addressed to CEO Anne Wojcicki,

Seven independent board members at DNA-testing company 23andMe Holding Co. ($ME) have resigned in protest over plans to take the company private.